Nucleic Acid Drug Developer

Gene Therapy and Gene Editing Technology Developer

Innovative Drug Developer

mRNA Therapeutics Developer
On January 4, Abogen announced the appointment of Iain McFadyen as the company's Chief AI Officer and member of the Scientific Advisory Board. Iain McFadyen previously served as Chief Data Science Officer at Tessera Therapeutics and LifeMine Therapeutics, and before that, as Vice President at Moderna.